Holen Sie sich die Stockscreener-App
7.96
6.91%
0.58
Schlusskurs vom Vortag:
$7.38
Offen:
$7.81
24-Stunden-Volumen:
6,322
Relative Volume:
0.02
Marktkapitalisierung:
$8.08M
Einnahmen:
$2.23M
Nettoeinkommen (Verlust:
$-12.33M
KGV:
-5.9639
EPS:
-1.3347
Netto-Cashflow:
$-11.75M
1W Leistung:
-3.78%
1M Leistung:
-23.40%
6M Leistung:
-9.47%
1J Leistung:
+31.50%
1-Tages-Spanne:
$7.47
$8.1599
1-Wochen-Bereich:
$7.33
$8.33
52-Wochen-Spanne:
$5.00
$27.90
Addex Therapeutics Ltd Adr Stock (ADXN) Company Profile
Firmenname
Addex Therapeutics Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie ADXN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| ADXN | 8.13 | 8.08M | 2.23M | -12.33M | -11.75M | -1.3347 |
| VRTX | 449.69 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 748.75 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 588.46 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 247.89 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 106.52 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Addex Therapeutics Ltd Adr Aktie (ADXN) Neueste Nachrichten
Addex Stock Soars on Crucial Update From Indivior Research Deal - MSN
Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year? - Yahoo Finance
Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024 - GlobeNewswire Inc.
Positive Trial Data on Symplicity RDN System Likely to Support MDT Stock - MSN
Are Medical Stocks Lagging Boston Scientific (BSX) This Year? - Yahoo Finance
What Makes Addex Therapeutics (ADXN) a New Buy Stock - Yahoo Finance
Earnings call: Addex Therapeutics reports half-year financials and R&D updates By Investing.com - Investing.com South Africa
Earnings call: Addex Therapeutics reports half-year financials and R&D updates - Investing.com
ADMA Biologics stock soars to all-time high of $19.36 - Investing.com
ADMA Biologics Stock Soars 76.2% in 3 Months: Right Time to Invest? - Zacks Investment Research
ADMA Biologics (NASDAQ:ADMA) Reaches New 52-Week High at $19.42 - MarketBeat
ADXN Stock on the Rise: A Promising Investment - The InvestChronicle
There Are Mixed Signals on the Chart for Addex Therapeutics Ltd ADR (ADXN) - US Post News
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Is Alcon (ALC) Outperforming Other Medical Stocks This Year? - Yahoo Canada Finance
Addex’s Partner Discontinues ADX71149 development in Epilepsy - GlobeNewswire Inc.
Addex Therapeutics presents results from GABAB PAM cough program - TipRanks
Addex Presents Positive Results from GABAB PAM Cough - GlobeNewswire Inc.
Addex To Present at the Thirteenth London International Cough Symposium (13th LICS) - GlobeNewswire Inc.
Addex to Participate at the Benchmark Company Healthcare House Call Conference - The Globe and Mail
Addex Therapeutics Ltd. Sponsored ADR (ADXN) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Canada Shine On
Earnings call: Addex Therapeutics reports on Q1 2024 with mixed results - Investing.com India
Earnings call: Addex Therapeutics reports on Q1 2024 with mixed results By Investing.com - Investing.com
Genocea (GNCA) Begins Phase I/IIa Study for Solid Tumor Drug - Yahoo Movies UK
Addex Therapeutics Ltd. Sponsored ADR (ADXN) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Movies UK
Addex Therapeutics Ltd. Sponsored ADR (ADXN) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Canada Shine On
Addex Therapeutics Ltd. Sponsored ADR (ADXN) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Movies Canada
Why Philips Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket - Benzinga
Addex Therapeutics Receives Nasdaq Approval for ADS Ratio Change By Investing.com - Investing.com India
Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici
ImmunoGen (IMGN) Reports Q2 Loss, Lags Revenue Estimates - Yahoo New Zealand News
Addex Therapeutics ADR (NASDAQ: ADXN) Has Moved an M4 PAMS Program to Optimization - BP Journal
The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer I - Benzinga
ASLAN Pharma (NASDAQ:ASLN) Stock Quotes, Forecast and News Summary - Benzinga
Addex Therapeutics (ADXN) Stock Price, News & Analysis - MarketBeat
The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Sh - Benzinga
ADXN Stock Price and Chart — SIX:ADXN - TradingView
Addex and the Charcot-Marie-Tooth Association enter collaboration to advance ADX71441 in Charcot-Marie-Tooth 1A ... - Yahoo Eurosport UK
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
Finanzdaten der Addex Therapeutics Ltd Adr-Aktie (ADXN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):